- ASSOCIATE PROFESSOR Health Evidence and Policy
- ASSOCIATE PROFESSOR Neurology
Dr. Boden-Albala is a social epidemiologist whose work has involved describing and intervening on stroke disparities with emphasis on social support and social networks and has extensive experience in the description of and intervention research associated with disparities especially among white, black and Hispanic and Alaskan Native populations in both urban and rural communities. She was formerly Director of the Community Engagement Resource of the Columbia University CTSA where part of her work focused on the role of Health Literacy in cardiovascular disease including the development of “accessible” materials and techniques to enhance decision making for lifestyle behaviors. She joined Mount Sinai Medical Center School of Medicine in early 2011 as Chief, Division of Social Epidemiology in the Department of Health Evidence and Policy. In this capacity, she is working with faculty to train a new cohort of disparities researchers. She has extensive experience investigating many well-known social determinants of health, including community, household, network and individual data, (2) testing measures including medical skepticism, entitlement expectations, perceived racism that will explore previously untested social determinants of cerebrovascular disease, (3) collecting extensive biological measures of neuroendocrine, metabolic, cardiovascular and immune parameters to investigate the biological manifestation of social conditions as disease states, (4) following a large sample of multi-ethnic stroke populations longitudinally and (5) using a community engaged philosophy to disseminate results and collect information. She is currently Principle Investigator (PI) of the National Initiative for Minority Involvement in Neurological Clinical Trials which is investigating the multi-level barriers to minority recruitment including lay barriers, attitudes and perception of researchers and institutional obstacles. She is also PI on the FURRThER Study, a complex behavioral trial; PI on the NINDS funded SWIFT stroke preparedness Study; PI on DESERVE an emergency room risk reduction intervention; PI on ASPIRE, a stroke preparedness intervention in Washington DC; multiple PI on the Alaska Native Stroke Registry, and is the director of the 12,000 community resident WICER survey.
Boden-Albala B, Roberts ET, Moats H, Arif H, Sacco RL, Paik MC. Community Level Disadvantage and the Likelihood of First Ischemic. Stroke. Epidemiology Research International 2012;: Article ID 481282, doi:10.1155/2012/481282.
Boden-Albala B, Roberts ET, Bazil C, Moon Y, De Rosa J, Rundek T, Elkind MS, Paik MC, Sacco RL. Daytime Sleepiness and Risk of Stroke in a multi-ethnic community. Circulation: Cardiovascular Quality and Outcomes 2012 Jul 1; 5(4): 500-7.
Boden-Albala B, Tehranifar P, Stillman J, Wright C, Howard JM, Andrews H, Perez T, Paik MC. Social Network Types and Acute Stroke Preparedness Behavior. Cerebrovascular Diseases Extra 2011; 1(1): 75-83.
Boden-Albala B, Carman H, Moran M, Doyle M, Paik MC. Stroke risk perception in a socially and economically diverse population of stroke and TIA survivors. Neuroepidemiology 2011; 37: 83-87.
Willey JZ, Disla N, Moon YP, Paik MC, Sacco RL, Boden-Albala B, Elkind MS, Wright C. Early depressed mood after stroke predicts long-term disability: the Northern Manhattan Stroke Study (NOMASS). Stroke 2010 Sep; 41(9): 1896-900.
Boden-Albala B, Stillman J, Perez T, Evensen L, Moats H, Wright C, Moon-Howard J, Doyle M, Paik MC. A stroke preparedness RCT in a multi-ethnic cohort: Design and methods. Contemporary Clinical Trials 2010 May; 31(3): 235-241.
Boden-Albala B, Kargman DE, Lin IF, Paik MC, Sacco RL, Berglund L. Increased Stroke Risk and Lipoprotein(a) in a Multi-ethnic Community: Findings from the Northern Manhattan Stroke Study. Cerebrovascular Disease 2010 Aug; 30(3): 237-243.
Boden-Albala B, Sacco RL, Lee HS, Grahame-Clarke C, Rundek T, Elkind MS, Giardina EG, DiTullio MR, Homma S, Paik MC. Metabolic Syndrome and the Risk of Vascular Events and Ischemic Stroke: Findings from the Northern Manhattan Study. Stroke 2008; 39: 30-35.
Boden-Albala B, Cammack S, Chong J, Wang C, Wright C, Rundek T, Elkind MS, Paik MC, Sacco RL. Diabetes, Fasting Glucose levels and risk of ischemic stroke and vascular events: Findings from the Northern Manhattan Study (NOMAS). Diabetes Care 2008 Jun; 31(6): 1132-1137.
Boden-Albala B, Link B, Litwak E, Sacco RL. Social Isolation and Outcomes Post Stroke. Neurology 2005 Jun; 64(11): 1888-1892.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Boden-Albala did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Icahn Medical Institute Floor 2nd Room L2-70
1425 Madison Avenue
New York, NY 10029